1536054-12-2

Upstream product

• 1536053-93-6 C₂₃H₃₀Br₂O₃Si 
• 1536053-95-8 (2S,4S)-4-((R)-3-bromobut-3-en-2-yl)-2-(4-methoxyphenyl)-1,3-dioxane 
• 135362-69-5 3-(4-methoxybenzyl)oxypropan-1-ol 
• 87318-97-6 (2S)-1-[(4S)-2,2-dimethyl[1,3]dioxolan-4-yl]pent-4-en-2-ol 
• 1536054-01-9 tert-butyl (S)-1-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)pent-4-en-2-yl carbonate 
• 1536054-03-1 tert-butyl (4S,6S)-6,7-dihydroxyhept-1-en-4-yl carbonate 
• 1536054-05-3 (4S,6S)-7-(benzyloxy)-6-hydroxyhept-1-en-4-yl tert-butyl carbonate 
• 69739-34-0 t-butyldimethylsiyl triflate 
• 1536054-10-0 (2S,5S)-1-((4S,6S)-6-(benzyloxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl)-5-((2S,4S)-2-(4-methoxyphenyl)-1,3-dioxan-4-yl)-4-methylenehexan-2-ol 
• 1536053-91-4 ((R)-3-((2S,4S)-2-(4-methoxyphenyl)-1,3-dioxan-4-yl)but-1-en-2-yl)dimethyl(phenyl)silane 

Downstream Products

• 1536054-15-5 (2R,5R)-6-((4R,6S)-6-((benzyloxy)methyl)-2,2-dimethyl-1,3-dioxan-4-yl)-5-((tert-butyldimethylsilyl)oxy)-2-((2S,4S)-2-(4-methoxyphenyl)-1,3-dioxan-4-yl)hexan-3-one 

Relevant academic research and scientific papers

Asymmetric alcohol C-H allylation and syn -Crotylation: C9-C20 of tetrafibricin

The C9-C20 segment of the fibrinogen receptor inhibitor tetrafibricin was prepared in 10 steps (longest linear sequence). Ruthenium catalyzed enantioselective syn-crotylation is used to construct C9-C13. Iridium catalyzed asymmetric alcohol C-H allylation